Zynex (ZYXI) Price & Analysis

Compare

814 Followers

ZYXI Stock Chart & Stats

$1.34

-$0.09(-1.11%)

At close: Jan 08 4:00 PM EST

$1.34

-$0.09(-1.11%)

Day’s Range― - ―

52-Week Range$1.05 - $9.33

Previous CloseN/A

Volume7.23K

Average Volume (3M)82.07K

Market Cap

$34.24M

Enterprise ValueN/A

Total Cash (Recent Filing)$17.54M

Total Debt (Recent Filing)$72.46M

Price to Earnings (P/E)―

Beta1.69

Next Earnings

Feb 26, 2026

EPS EstimateN/A

Last Dividend Ex-Date

Jan 05, 2022

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding30,297,441

10 Day Avg. Volume98,176

30 Day Avg. Volume82,070

Financial Highlights & Ratios

PEG Ratio-1.28

Price to Book (P/B)7.16

Price to Sales (P/S)1.33

P/FCF Ratio21.07

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)-1.32

Revenue Forecast (FY)$94.77M

Bulls Say, Bears Say

Bulls Say

Leadership ChangeSteven Dyson, with over 25 years of experience in the medical technology sector, has been appointed as CEO to refocus Zynex's business strategy and return it to a strong growth trajectory.

Market ExpansionNiCO, if cleared by the FDA, would allow Zynex to enter the $2.8 billion pulse oximetry market with differentiating precision and accuracy in hospital and non-hospital settings.

Bears Say

Potential DilutionPotential dilution risk is noted as a concern for Zynex's stock value.

Regulatory RisksRisks include slower-than-anticipated revenue growth due to competition and inability to secure regulatory clearance for other medical devices.

Revenue DeclineTotal revenue was $22.3M, representing 55% YoY decline and missing our projection of $27.0M.

Zynex News

Zynex CCO Resigns Amid Separation Negotiations

An announcement from Zynex ( ($ZYXI) ) is now available. Zynex, Inc. announced that Anna Lucsok resigned as...

8d ago

ZYXI

Is ZYXI a Buy, Before Earnings?

Zynex Inc (ZYXI) is scheduled to report 3rd quarter earnings on 10/23/2025. Regarding Q3 estimates, Wall Street analysts...

19d ago

ZYXI

Zynex Expands Board, Appoints New Director

Zynex ( ($ZYXI) ) has shared an update. On October 7, 2025, Zynex, Inc. expanded its Board of...

25d ago

ZYXI

Zynex Seeks Partner for NiCO CO-Oximeter Commercialization

Zynex ( ($ZYXI) ) has provided an update. On October 1, 2025, Zynex, Inc. announced a strategic shift...

1M ago

ZYXI

Zynex Appoints Anna Lucsok as Chief Commercial Officer

Zynex ( ($ZYXI) ) has issued an update. On September 16, 2025, Anna Lucsok transitioned from the role...

2M ago

ZYXI

Zynex Appoints New CFO and CLO Amid Leadership Changes

Zynex ( ($ZYXI) ) has issued an announcement. On August 18, 2025, Zynex, Inc. announced the appointment of...

3M ago

ZYXI

Zynex announces new executive team

On June 30, the company announced the Board’s appointment of Steven Dyson as the incoming CEO. Since that...

3M ago

ZYXI

Zynex Inc. Faces Challenges Amid Strategic Shifts

Zynex Inc (($ZYXI)) has held its Q2 earnings call. Read on for the main highlights of the call....

3M ago

ZYXI

Ladenburg upgrades Zynex, says NiCO opportunity ‘should not be overlooked’

As previously reported, Ladenburg upgraded Zynex (ZYXI) to Buy from Neutral with a $3.70 price target While the...

3M ago

ZYXI

Zynex upgraded to Buy from Neutral at Ladenburg

Ladenburg upgraded Zynex (ZYXI) to Buy from Neutral with a $3.70 price target Published first on TheFly –...

3M ago

ZYXI

Zynex downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright analyst Yi Chen downgraded Zynex (ZYXI) to Neutral from Buy without a price target The company...

3M ago

ZYXI

Zynex Inc. Faces Financial Challenges Amid Strategic Shifts

Zynex Inc ( ($ZYXI) ) has released its Q2 earnings. Here is a breakdown of the information Zynex...

3M ago

ZYXI

Zynex suspends guidance

Zynex (ZYXI) announced that with the retirement of current CEO and the announced departure of its CFO, the...

3M ago

ZYXI

Zynex reports Q2 EPS (66c) with items vs. 4c last year

Q2 EPS includes a non-cash adjustement of (66c) per share. Reports Q2 revenue $22.3M, consensus $27.38M. “In Q2,...

3M ago

ZYXI

ZYXI FAQ

What was Zynex Inc’s price range in the past 12 months?

Zynex Inc lowest stock price was $1.05 and its highest was $9.33 in the past 12 months.

What is Zynex Inc’s market cap?

Zynex Inc’s market cap is $34.24M.

When is Zynex Inc’s upcoming earnings report date?

Zynex Inc’s upcoming earnings report date is Feb 26, 2026 which is in 109 days.

How were Zynex Inc’s earnings last quarter?

Currently, no data Available

Is Zynex Inc overvalued?

According to Wall Street analysts Zynex Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Zynex Inc pay dividends?

Zynex Inc pays a Notavailable dividend of $0.091 which represents an annual dividend yield of N/A. See more information on Zynex Inc dividends here

What is Zynex Inc’s EPS estimate?

Zynex Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zynex Inc have?

Zynex Inc has 30,297,441 shares outstanding.

What happened to Zynex Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Zynex Inc?

Currently, no hedge funds are holding shares in ZYXI

Zynex Stock Smart Score

Underperform

Fundamentals

Return on Equity

-168.22%

Trailing 12-Months

Asset Growth

-29.51%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Zynex Inc

Zynex, Inc. (NASDAQ: ZYXI) is a medical technology company based in the United States that specializes in developing and manufacturing non-invasive medical devices for pain management and rehabilitation. The company focuses on innovative electrotherapy products, particularly its NexWave and NeuroMove devices, which are designed to provide relief from chronic pain and assist in physical rehabilitation. Zynex operates primarily in the healthcare sector, catering to both patients and medical professionals, with a commitment to enhancing quality of life through advanced medical technologies.

Zynex (ZYXI) Earnings & Revenues

Historic Earnings Reports

ZYXI Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Negative

The earnings call highlighted significant challenges, including a sharp revenue decline and ongoing issues with TRICARE payment suspension. However, the company's efforts to reduce costs, improve cash flow, and advance new products like the NiCO pulse oximeter provide some positive outlook for future growth. The appointment of a new CEO also signals a strategic refocus. Despite these efforts, the challenges currently outweigh the positive developments.View all ZYXI earnings summaries

ZYXI Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","9":"$9","2.25":"$2.25","4.5":"$4.5","6.75":"$6.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.70</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.25,4.5,6.75,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,1.6138461538461537,1.7876923076923077,1.9615384615384617,2.1353846153846154,2.309230769230769,2.483076923076923,2.656923076923077,2.830769230769231,3.0046153846153847,3.178461538461539,3.3523076923076927,3.5261538461538464,{"y":3.7,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,1.3292307692307692,1.2184615384615385,1.1076923076923078,0.9969230769230769,0.8861538461538462,0.7753846153846153,0.6646153846153846,0.5538461538461539,0.44307692307692315,0.3323076923076924,0.22153846153846168,0.11076923076923073,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.44,1.6138461538461537,1.7876923076923077,1.9615384615384617,2.1353846153846154,2.309230769230769,2.483076923076923,2.656923076923077,2.830769230769231,3.0046153846153847,3.178461538461539,3.3523076923076927,3.5261538461538464,{"y":3.7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.92,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.86,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.83,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.76,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.22,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.01,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.21,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.48,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.01,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.02,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.66,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >